Zoltan Csanadi

Radiofrequency catheter ablation of premature ventricular complexes improved left ventricular function in a non-responder to cardiac resynchronization therapy.

Reduction in ventricular pacing after AV node modification in a patient with dual-chamber pacemaker: what is the mechanism?

Pacemaker-mediated tachycardia over the upper rate limit in a biventricular pacemaker system: what is the mechanism?

Adenosine-dependent concealed accessory pathway.

Long-term arrhythmia variability after monomorphic ventricular tachycardia in patients with an implantable cardioverter defibrillator.

The Seattle Heart Failure Model predicts survival in patients with cardiac resynchronization therapy: a validation study.

ST-segment elevation followed by progressive widening of the QRS complex.

Transcranial measurement of cerebral microembolic signals during pulmonary vein isolation: a comparison of two ablation techniques.

Electrical storm in the brain and in the heart: epilepsy and Brugada syndrome.

Predictors of cerebral microembolization during phased radiofrequency ablation of atrial fibrillation: analysis of biophysical parameters from the ablation generator.

New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.

Cerebral microembolization during atrial fibrillation ablation: comparison of different single-shot ablation techniques.

Predictors of cerebral microembolization during phased radiofrequency ablation of atrial fibrillation: role of the ongoing rhythm and the site of energy delivery.

Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial.

Cerebrovascular Complications Related to Atrial Fibrillation Ablation and Strategies for Periprocedural Stroke Prevention.

Atrial Fibrillation Ablation and Stroke.

Phased RF Ablation: Results and Concerns.

Circulating ACE2 activity correlates with cardiovascular disease development.

Cerebral micro-embolization during pulmonary vein isolation: Relation to post-ablation silent cerebral ischemia.

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke.

Relationship between cardiovascular diseases and circulating cell-free nucleic acids in human plasma.

PITX2 and NEURL1 SNP polymorphisms in Hungarian atrial fibrillation patients determined by quantitative real-time PCR and melting curve analysis.

Quantification of peripheral whole blood, cell-free plasma and exosome encapsulated mitochondrial DNA copy numbers in patients with atrial fibrillation.

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.

Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome.

Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques.

Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.

Negative Inotropic Effect of BGP-15 on the Human Right Atrial Myocardium.

The impact of hydrostatic pressure on the result of physiological measurements in various coronary segments.

Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation.